USD 12 million investment announced by Amway for India expansion

An investment of USD 12 million (around ₹100 crore) over the next three to five years has been announced by US-based direct selling major Amway for its India operations. The investment is intended to expand physical stores and improve customer experience, with India expected to become one of Amway’s top three global markets.

During his maiden visit to India since assuming charge, Amway President and Global CEO Michael Nelson stated in an interview with PTI Videos that the commitment was being discussed with his team this week. “An additional USD 12 million investment is being committed,” Nelson said.

Focus on Community and Experience :

The new investment is being directed primarily toward the establishment of experience-driven stores across the country. These stores are being designed to serve as community hubs where Amway Business Owners (ABOs) can bring customers, conduct training sessions, and showcase products. Through this initiative, distributor capabilities are being enhanced, Amway’s physical presence is being strengthened, and customer engagement is being elevated.

R&D and Export Expansion :

Continued expansion of research and development (R&D) activities is also being planned in India, where four laboratories have already been set up. It was noted that India has been designated as one of Amway’s three global manufacturing hubs, alongside the United States and China. “Continued investments are being made into our R&D laboratories and shared services organisation in India,” Nelson mentioned.

A total of USD 140 million has been invested in India to date, and further enhancement of exports from Amway’s Madurai manufacturing facility is being pursued. The plant currently produces Amway’s complete product range for India and supplies it to Southeast Asian markets. “More exports from our Indian plant to other markets are being seen,” Nelson added.

India’s Strategic Role :

India was described as a growth market with significant potential, having already become a top-10 global market for Amway and continuing to advance. The country’s demographics, innovation, and entrepreneurial nature were cited as major enablers of growth.

Consumer Shift and Regulatory Climate :

A noticeable shift in consumer focus toward personal health and wellbeing was observed following the pandemic, an area to which Amway’s core product line, including Nutrilite, is aligned. “Greater awareness among Indian consumers about their personal health has been observed, especially after the pandemic,” Nelson said.

It was acknowledged that regulatory challenges may have had an impact on Amway’s earlier growth, though the 2021 direct selling regulations were credited with providing clarity and protecting consumers. “The reforms that have made it easier for international companies to do business in India are being appreciated,” Nelson said, noting that collaboration with the government is continuing to address remaining challenges.

‘Make in India’ and Local Sourcing :

Benefits from the ‘Make in India’ initiative have been experienced by Amway, particularly in mitigating the effects of international trade tensions and tariffs. “Many risks that could have arisen from global trade issues have been mitigated because manufacturing is being done in India,” Nelson said.

Local sourcing is also being emphasized, with 29 certified organic farms in India producing raw materials for Amway’s Nutrilite nutrition products, thereby reducing dependence on global supply chains.

Direct Selling in a Digital Era :

Although the rise of e-commerce is being recognized, direct selling is being positioned as Amway’s differentiator in the Indian market. “A distinct advantage is being created by reaching customers through and with our business owners,” Nelson stated.

India’s strong entrepreneurial spirit is being viewed as a key driver for Amway’s growth, with the company’s business model being seen as an opportunity for individuals to own their own ventures and achieve self-employment goals.